PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19056168-1	2009	Although inhibition of cyclooxygenase-2 (COX-2) or activation of peroxisome proliferators-activated receptor gamma (PPAR-gamma) leads to growth inhibition in malignancies, the synergistic anti-tumor effects of combination of COX-2 inhibitor (NS-398) and PPAR-gamma agonist (rosiglitazone) on the human pancreatic cancer cells remains unknown.	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	242-248	peroxisome proliferator activated receptor gamma	Homo sapiens	116-126	
14555539-9	2003	This down-regulation of PPARgamma mRNA by EGF was blocked in the presence of NS-398, a selective COX-2 inhibitor.	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	77-83	peroxisome proliferator activated receptor gamma	Homo sapiens	24-33	
12736714-3	2003	Treatment of MDA-MB-231 breast cancer cells with NS-398 (a COX-2 inhibitor) or ciglitazone (CGZ, a PPARgamma-ligand) significantly inhibited cell proliferation and markedly increased apoptotic rates.	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	49-55	peroxisome proliferator activated receptor gamma	Homo sapiens	99-108	
11809750-4	2002	The cyclooxygenase-2 inhibitor NS398 blocked PPARgamma-induced PGE(2) secretion.	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	31-36	peroxisome proliferator activated receptor gamma	Homo sapiens	45-54	
26863638-8	2016	Fluorescence microscopy analyses revealed a lovastatin-induced cytosol-to-nucleus translocation of PPARgamma that was inhibited by NS-398.	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	131-137	peroxisome proliferator activated receptor gamma	Homo sapiens	99-108	
23943857-6	2013	Celecoxib-elicited PPARgamma translocation was inhibited by NS-398.	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	60-66	peroxisome proliferator activated receptor gamma	Homo sapiens	19-28